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Abstract
Integrons are mobilizable platforms-DNA elements with impacts on moving antibiotic resistance genes among bacteria and 
capable of spreading multi-drug resistance (MDR) in pathogens. Methicillin-resistant Staphylococcus aureus (MRSA) strains 
are the main cause of community-acquired and nosocomial infections with high mortality and morbidity rates worldwide. 
This work is mainly aimed at calculating the frequency of Type I, II, and III integrons within multi-drug resistance and 
Methicillin-resistant S. aureus Isolates in Iran. In this cross-sectional study, 230 clinical isolates of S. aureus were gathered 
from patients of educational hospitals in the provinces of Iran. These isolates were verified utilizing particular biochemical 
examinations and then assessed for antibiotic susceptibility through disk diffusion technique and standard procedures were 
done. Genomic and plasmid DNA of all isolates were extracted using Extraction Kit and PCR assay was used for the detection 
of Type I, II and III integrons genes. Out of the 230 S. aureus isolates, 136 (59.1%) isolates were MRSA and 141 (61.3%) 
isolates exhibited the MDR pattern. PCR and sequencing showed that 57 (24.8%) of tested isolates carry Type I integron. 
Among the isolates investigated, MRSA and MDR isolates showed frequencies of 56.1% and 57.9%, respectively. Type II 
and III integrons were found in none of 230 isolates. The IntI I gene was present in approximately one-quarter of this study 
isolates. The great prevalence rate of MDR and MRSA isolates and concurrently the existence of Type I integron among 
those isolates have been considered an important concern in medical society.
Introduction
Staphylococcus aureus is a non-motile, Gram-positive, fac-
ultatively anaerobic, and omnipresent coccus existing in 
mainly the skin and mucosal membranes of humans [1]. S. 
aureus is in charge of an extensive range of infections, com-
prising folliculitis, acne, abscess, and wound infections, and 
life-threatening infections such as sepsis, osteomyelitis, toxic 
shock syndrome (TSS), food poisoning, bacteremia, and 
endocarditis [1]. S. aureus infections, mostly in pyogenic 
and acute types, as well as being able to spread to other body 
tissues Staphylococcus aureus is identified as being one of 
the world’s leading sources of hospital-acquired infections 
[1, 2]. In this case, antibiotic resistance of S. aureus is none-
theless a principal concern in the remedy of infectious ill-
nesses owing to the misapplication of traditional antibiotics 
[1–3].
Methicillin, a β-lactamase-resistant antimicrobial agent, 
used to be represented in 1959 and the primary reported case 
of methicillin-resistant S. aureus (MRSA) from London in 
1961 [3]. It was proposed that the mecA gene is the major 
cause of resistance to methicillin. mecA encrypts a mutated 
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penicillin-binding protein (i.e., PBP2a) with a low attrac-
tion for β-lactam antibiotics [4, 5]. The multi-drug resist-
ance phenomenon, seen principally in MRSA strains, is the 
main agent of treatment loss and enlarge in treatment costs 
in healthcare systems [6]. Notably, MRSA infections are 
correlated to an overhead mortality rate in comparison with 
methicillin-susceptible S. aureus infections [7, 8].
MRSA was formerly supposed as a nosocomial patho-
gen, however, over the previous 20 years, reports propound 
an extending drift for community-associated MRSA (CA-
MRSA). These clones probably substitute the present 
healthcare-related MRSA (HA-MRSA) clones in the future. 
Recent reports have exposed an increment in the global inci-
dence of MRSA [3, 5, 6].
The S. aureus turns to MRSA strains by gaining the mecA 
gene [4]. This acquisition has done by the mobile genetic 
elements (MGEs) that can move around within a genome, 
or that can be transferred from one species or replicon to 
another [6]. The MGEs for instance integrons, transposons, 
and plasmids are also liable for acquiring and addition-
ally the extent of antibiotic resistance genes [9, 10]. The 
integrons’ function has been conceived inasmuch movable 
genetic apparatus in the horizontal transferring of the anti-
microbial resistance genes in bacteria [11, 12]. Likewise, 
the integron horizontal transfer is determined as the most 
potent procedure of extending antimicrobial resistance genes 
and making multidrug-resistant (MDRs) cases [9]. Besides, 
diverse types of integrons were determined in terms of the 
contrariety in their integrase gene elements [9]. The Type 
I integrons possess the topmost periodicity within Gram-
negative bacteria and Gram-positive bacteria separated from 
medical samples [9, 13]. The Type II integrons possess a 
lower incidence rate than Type I integrons revealed further 
in Gram-negative bacteria. Type III integrons emerge to be 
much less common (ranged from 0 to 10%.) and so are less 
enthralled in the spread of multidrug resistance [9, 13].
In structurally, the integrons have composed of three 
DNA sections such as a 5′ conserved section (5′ CS) encod-
ing a recombinase (integrase) [13]. This section admits for 
site-particular incorporation of drug resistance gene clusters 
between two greatly retained near head nucleotide sequences 
5′ CS and 3′ CS, an inside mutable region with one or fur-
ther resistance gene cassettes with various sequences and 
lengths, and a 3′ conserved segment (3′ CS) [9, 10, 13]. The 
3′ CS contains a quaternary ammonium compound resist-
ance gene, an unknown function. Moreover, the integrons 
transfer resistance gene elements in the genetic cassette 
by consolidation within chromosomes, transposons, and 
plasmids. The integrons deliver further exuberant antibi-
otic resistance genes and these genes have a contribution 
in producing resistance against various antibiotics, such as 
aminoglycosides, macrolides, β-lactams, chloramphenicol, 
and sulfonamides [9, 13, 14].
We did not find a recent complete investigation in Iran 
that indicates all of the integrons in S.aureus. For this rea-
son, regarding the frequency of Type I, II, and III integrons 
in S. aureus isolates, we conducted our analysis in four prov-
inces that include Isfahan, Qom, Kashan, and Tehran. There-
fore, this work was mainly aimed to calculate the frequency 
of Type I, II, and III integrons in methicillin-resistant S. 
aureus (MRSA) and multi-drug resistance S. aureus (MDR) 
isolates from clinical samples in the center, Iran.
Materials and Methods
This cross-sectional report was done on 230 strain of S. 
aureus isolated from various samples of patients such as 
urine, wound, blood, catheter, trachea, abscess, and syno-
vial fluid. These samples were collected at four provinces 
that including Isfahan (Al-Zahra hospital), Kashan (Sha-
hid-Beheshti), Qom (Shahid Beheshti), and Tehran (Masih-
Daneshvari) from January 2018 to September 2019.
All procedures performed in this study were following 
the ethical standards of the Kashan university of medical 
sciences, and the 1964 Helsinki Declaration and its later 
amendments. Informed consent was obtained from the 
patient involved in the study.
The isolates were recognized utilizing standard biochemi-
cal examinations such as Gram staining, oxidase disk test 
(Himedia Co., India), catalase, DNAase (Himedia Co., 
India), coagulase tube test, mannitol fermentation (MSA, 
(Himedia Co., India), and Novobiocin susceptibility test 
(Himedia Co., India). After the ultimate identifying, the 
isolates of S. aureus were analyzed to femA, a cytoplasmic 
protein essential for expressing the methicillin resistance 
in Staphylococcus aureus included in biosynthesizing the 
staphylococcal cell [15, 16], the PCR test was done for all 
isolates.
The antibiotic susceptibility test was done in terms of 
the Kirby-Bauer disk diffusion technique at turbidity of 0.5 
McFarland standards on Mueller–Hinton agar (Himedia Co., 
India) plates regarding the Clinical and Laboratory Stand-
ards Institute guidelines (CLSI 2018 edition) [17].
In our work, 16 antibiotic disks (MAST, UK) were 
used such as piperacillin/Tazobactam (110 µg), Imipenem 
(10 µg), Cefuroxime (30 µg), Moxifloxacin (5 µg), Levoflox-
acin (5 µg), amikacin (30 µg), gentamicin (10 µg), rifampicin 
(5 µg), tobramycin (10 µg), linezolid (30 µg), penicillin 
(5 µg), clindamycin (2 µg), vancomycin (30 µg), levofloxacin 
(5 µg), ciprofloxacin (5 µg), and co-trimoxazole (25 µg) to 
detect MRSA and MSSA strains. The bacterium suspension 
was extended on Mueller–Hinton agar medium (Himedia 
Co., India) after incubating at 37 °C and then compared 
with a 0.5 McFarland standard. Then, the antibiotic disks 
were positioned on the medium. The diameters of growth 
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inhibition area were measured after incubating for 24 h in 
an incubator and compared with CLSI tables. To control the 
disk’s quality, and S. aureus standard strain (ATCC 25923) 
was utilized for antibiogram test. The positive samples 
template DNA was made utilizing a Gene MATRIX Quick 
Blood DNA Purification Kit (EURx Ltd., Gdansk, Poland) 
based on the instructions of the manufacturer.
The PCR was similarly conducted to determine the genes 
for femA gene detection and genes of Type I, II, and III 
integrons via their definite primers (SinaClon Co., Iran) 
(Table 1). The products have done with an ultimate volume 
of 25 µL with 12.5 µL of Master Mix (SinaClon Co., Iran), 
2 µL of bacterial DNA, 1 µL of each primer, and sterile 
distilled water to 25 µL. The PCR thermal cycles for inte-
gron and femA genes contained primary denaturation for 
5 min at 94 °C, after 35 main cycles and an ultimate exten-
sion at 72 °C for integron and femA genes for 7 and 2 min, 
respectively (Table 1) [15, 16]. In the end, the PCR products 
were examined using the 2% agarose gel electrophoresis and 
stained with SYBR Safe DNA and visualized and pictured 
through a transilluminator (UVITEC Alliance 4.7, Bio-
Active., Ltd., Bangkok, Thailand). We used femA-negative 
control and femA-positive control (S. aureus ATCC 33591) 
(S.epidermidis ATCC 2228).
Results
In this report, out of the 230 S. aureus isolates, 136 (59.1%) 
isolates were MRSA and 141 (61.3%) isolates exhibited 
the MDR pattern. In this report, out of 230 isolates of S. 
aureus, 141 (61.3%) were obtained in men and 89 (38.7%) 
in women, with a total mean age of, was 44.8 years. The 
major ward of the hospital that we obtained our samples 
was an internal ward with 110 samples (47.6%). The great-
est isolates frequency was obtained in blood specimens (n 
= 32, 22.7%), urine specimens (n = 7, 5%), respiratory tract 
infusions (n = 21, 36.2%), skin and soft tissue samples (n = 
21, 14.9%), cutaneous ulceration samples (n = 20, 14.2%), 
and catheter samples (n = 11, 7.1%). PCR and sequencing 
showed that 57 (24.8%) of tested isolates carried Type I 
integron (Fig. 1). Among the isolates investigated, MRSA 
and MDR isolates showed frequencies of 56.1% and 57.9%, 
respectively. Among the isolates, MDR and Non-MDR iso-
lates represented integron I frequencies of 23.4% and 26.9%, 
respectively. The antibiotic susceptibility panel for integron 
positive isolate is shown in Tables 2 and 3. 
Discussion
Staphylococcus aureus is an adaptable and successful 
human pathogen [4]. The increasing incidence of MRSA 
and S. aureus results in the incremented occurrences of 
community-acquired and hospital-acquired infections all 
over the world creating a key public health concern [4, 5]. 
The horizontal carrying of resistance genes through inte-
grons [10]. This action is a key route of antibiotic resistance 
[10]. The integrons are mobile genetic elements that pass 
gene cassettes capable of dispersing MDR isolates and then 
limit options for treatment for controlling infectious diseases 
[9]. The presence of these components, in particular Type 
Table 1  Primer sequences of 
target genes and lengths of 
aimed products
Genes Primers(5′–3′) Size of amplified prod-
uct (bp)
References
femA F-AAA AAA GCA CAT AAC AAG CG 132 [16]
R-GAT AAA GAA GAA ACC AGC AG
IntI I F-CCT CCC GCA CGA TGATC 280 [18]
R-TCC ACG CAT CGT CAGGC 
IntI II F-GTA GCA AAC GAG TGA CGA AATG 788 [19]
R-CAC GGA TAT GCG ACA AAA AGGT 
IntI III F-GCC TCC GGC AGC GAC TTT CAG 433 [20]
R-GAT GCT GCC CAG GGC GCT CG
Fig. 1  Electropherogram of PCR amplification products of the class I 
integron in lanes of 1, 3, 4, 5 and 6 (280 bp). The middle line is DNA 
marker; and femA gene PCR amplification (120  bp). PCR bands 
show that the amplification products of class I integron was 280 bp
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I integrons, is one of the causes of the emergence of MDR 
isolates [11, 13].
Integrons were defined in almost 9% of the bacterial 
genomes, with Type I integron construction as the most 
global and most frequently reported one [9, 18]. Numer-
ous reports indicated that this type of integron can capture 
gene cassettes and encrypt resistance against quaternary 
sulfonamide and ammonium salts [14]. As the organization 
of Type I integron, Type II integron is usually related to the 
Tn7 transposon group. In this study, it was found that the 
frequency of Type I and II integrons is 47.7% and 17.4%, 
respectively. Compare with Type II integron, Type III inte-
gron includes the same structure, the incidence and recog-
nition rate of Type III integron are in the range of 0 to 10% 
[9, 11, 13, 14, 19].
In a recent work, performed by Ghasemian et  al., in 
2015, in 219 strains of Staphylococcus aureus, out of 64 
methicillin-resistant isolates, 56% had MDR pattern [20]. 
In another study recently conducted by Diba et al., partners 
carried out in Ardabil showed that the frequency of 46.3% 
isolates was MRSA, which were isolated from two teach-
ing hospitals in Ardabil [8]. Also in another study in Iran 
conducted by Javadi et al. 46.2% of Staphylococcus aureus 
isolates have multiple drug resistance patterns [21]. In the 
current report in 2019 by Mohammadi et al. in Isfahan that 
reported a 30% prevalence of MRSA in 150 various clinical 
specimens [22]. Our findings showed a greater prevalence of 
MRSA and MDR in comparison with the previous four stud-
ies. But according to a study by Rezazadeh et al. (2013) in 
Arak, 81 (81%) of 111, Staphylococcus aureus isolates were 
able to tolerate methicillin resistance by both phenotypic and 
genotypic methods [23]. Therefore, our current study has a 
lower prevalence rate than the previous report.
The results of this study showed that 57 (24.8%) of 231 
isolates of S.aureus carried the IntI I gene and the frequency 
of this gene among strains was 23.5% for MRSA and 23.4% 
for MDR among isolates. Despite extensive studies among 
gram-negative bacteria, fewer reports exist regarding gram-
positive bacteria. However, in the last 2 to 3 years, the 
existence of integron types has attracted much attention in 
S.aureus.
In Iran, Javadi et al., during a study in Tehran in 118 
isolates of Staphylococcus aureus, revealed that 31 isolates 
were positive for the existence of the IntI I gene [21]. In the 
study of Veise et al. from Iran, among the 200 Staphylococci 
spp., 81 (40.5%) isolates were Type I integron carriers [19]. 
Our report was same with these two reports that indicated 
Integron Type I only typed in clinical specimens. But in 
district report in Iran, in a report by Mostafa et al. in Tehran, 
Iran in 2015, they reported amongst 139 S. aureus isolates, 
Table 2  Results of antibiotic 
resistance of integron positive 
isolates vs integron negative 
isolates of S. aureus isolates
Antibiotic Antibiotic Susceptibil-
ity
Integron-positive 
isolates
Integron-negative 
isolates
P value
R (%) I (%) S (%) R (%) I (%) S (%) R (%) I (%) S (%)
Gentamycin 47 1.3 51.7 10.5 0.4 13.9 36.5 0.9 37.8 0.52
Amikacin 46.1 6.5 47.4 10.9 1.7 12.2 35.2 4.8 35.2 0.88
Tobramycin 47 3.9 49.1 10.5 1.3 13 36.5 2.6 36.1 0.56
Rifampicin 36.5 1.3 62.2 10.4 0.4 13.9 26.1 0.9 48.3 0.41
Penicillin 97.8 0 2.2 24.3 0 0.4 73.5 0 1.7 0.80
Oxacillin 39.6 3 57.4 10.4 0.9 13.5 29.1 2.2 43.9 0.77
Ciprofloxacin 50 6.5 43.5 13.5 1.3 10 36.5 5.2 33.5 0.78
Levofloxacin 43.5 3.5 53 12.2 0 12.6 31.3 3.5 40.4 0.22
Moxifloxacin 42.2 4.3 53.5 11.3 1.3 12.2 30.9 3 41.3 0.71
Co-Trimoxazol 17 0.4 82.6 3.1 0.4 21.3 13.9 0 61.3 0.15
Teicoplanin 4.4 17 78.7 0.9 4.3 19.6 3.5 12.6 59.1 0.93
Clindamycin 37.4 3.9 58.7 10 0.9 13.9 27.4 3 44.8 0.88
Erythromycin 45.2 10.9 43.9 12.2 1.3 11.3 33 9.6 32.6 0.31
Linezolid 2.6 0 97.4 0.9 0 23.9 1.7 0 73.5 0.63
Chloramphenicol 3.5 9.6 87 0 21.7 3 3.5 6.5 65.2 0.21
Tetracycline 58.3 3 38.7 14.8 0.9 9.1 43.5 2.2 29.6 0.88
Table 3  Results of antibiotic resistance of integron positive isolates 
VS integron negative isolates of S. aureus Isolates
Frequency rate Integron class I Frequency rate
Isolates
N = 230
Positive Negative Isolates
N = 230
Positive Negative
MDR
N = 141
33
(23.4%)
108
(76.6%)
MRSA
N = 136
32
(23.5%)
104
(76.5%)
NON-MDR
N = 89
24
(26.9%)
65
(73.1%)
MSSA
N = 94
20
(26.6%)
69
(73.4%)
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112 (80.5%) and 109 (78.4%) strains were taken into account 
as mecA positive and multidrug-resistant, respectively, that 
Type I integrons were found in 72.6% and Type II integrons 
35.2% of S. aureus clinical isolates, respectively [24]. This 
prevalence is a lower percentage VS global incidences, but 
in other countries, the scope of these changes is wider and 
wider, in China, there are several reports that Xu et al. in 
two separate studies showed that in the primary study of 
179 methicillin-resistant Staphylococcus aureus isolates 
42.5% of MRSA with Type I integrons [14], and in the sec-
ond investigations of 30 isolates of Staphylococcus aureus, 
53% (16 isolates) had this gene [25]. In Ren et al. report 
published in 2013 in China, from 180 isolates of Staphy-
lococcus aureus, the positive rate of Type I integrons was 
39.44% and the positive rate of Integron2 was 5.88% [26]. 
Our report revealed that there were not any IntI II in clinical 
samples and it is a very interesting issue that epidemiologi-
cal features will need to obvious these differences. In India 
in 2015 by Maratha et al. 143 isolates were mecA positive 
and in total, 71% of the MRSA isolates were carriers of Type 
I integrons, since none of the examined isolates were posi-
tive for IntI II and IntI III [27]. Therefore, it can be presumed 
that the prevalence of other Types of integron other than IntI 
I is not common in S. aureus. It is considered, contrary to 
our expectation in this work, no significant association was 
observed within the existence of Type I integrons and the 
antibiotic susceptibility phenotypes in 57 isolates. It seems 
that most of the studied isolates lack the target gene cassettes 
on their integron Type I and other mechanisms are involved 
in the development of resistance. There were differences 
between the results of this study and those of other studies 
in our country and elsewhere in the world. The reason for 
the difference in the frequency and prevalence of antibiotic 
resistance was related to the different populations and even 
hospitals and even between populations of a population that 
could be associated with irrational antibiotic use in these 
areas.
A   s t a t i s t i c a l l y   s i g n i f i c a n t   a s s o c i a -
tion was also observed in integrons positive aminoglyco-
sides consistent with findings from other studies. In 2018, 
in a study in China, the aminoglycoside resistance of all S. 
aureus isolates that were integron-positive categorized in 
Type I, while no Types II and III integrons were observed 
[28].
Also, a relationship was found between the incidence 
of Type I integron and antibiotic resistance of gentamicin, 
tetracycline, erythromycin, and co-trimoxazole by Xu et al. 
This issue representing the existence of various gene cas-
settes on mobile genetic elements like as integrons and 
therefore the integrons’ role in the incidence of antibiotic 
resistance in these bacterial isolates [14]. The existing find-
ings approved these MGEs’ role in transferring and spread-
ing different drug resistance patterns [19, 21, 28–32]. The 
high incidence of antibiotic resistance among bacterial 
pathogens is currently a key public health issue. Within 
our work, all S. aureus isolates had resistance to penicil-
lin (97.9%), consistent with the findings of other studies. 
However, no high resistance rate was found to gentamicin 
(47%), clindamycin (37.4%), and amikacin (46.1%). Safari 
et al. highlighted the great resistance levels in S. aureus 
isolates to clindamycin, gentamicin, and ciprofloxacin, not 
consistent with our results [33]. The resistance rates to tet-
racycline (58.3%), gentamicin (47%), ciprofloxacin (50%), 
and tobramycin (47%) in S. aureus isolates were consistent 
with another report [21, 24, 32–34]. The greatest isolates 
susceptibility denoted for penicillin (97.9%) and tetracycline 
(58.3%). In this work, 2.6% of the isolates had resistance to 
linezolid. In the study of Goudarzi et al., no resistance of 
the S. aureus was found to linezolid [29]; however, Mostafa 
et al. reported 17.3% of the isolates resistant to this antibiotic 
[24]. In the study of Poorabbas et al., it was found that the 
lowest resistance rates were related to co-trimoxazole and 
rifampin (10%) and clindamycin (24%) [35], however, in the 
current work, the lowest resistance was to linezolid (2.6%), 
chloramphenicol (3.4%), and teicoplanin (4.3%).
One of the restrictions of the current work was not an 
assessment of the frequency of possible gene clusters on 
integrons. Considering the integrons frequency amongst 
resistant strains of S. aureus and the risk of fast transferring 
of these agents in these isolates, it is necessary to identify 
isolates with integrons and their association with patterns 
of antibiotic resistance, to monitor patterns of resistance, 
and to choose acceptable antibiotics using genotypic and 
phenotypic resistance measurement results performed by 
hospital laboratories that are involved in the reduction of 
antibiotic resistance.
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